Results 261 to 270 of about 191,796 (284)

Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study

Lancet, The, 2009
Jean-Philippe Collet, Jean-Sébastien Hulot, Eric Villard   +2 more
exaly  

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

New England Journal of Medicine, 2009
Lars Wallentin, Richard C Becker, Andrzej J Budaj   +2 more
exaly  

Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease

Circulation, 2009
Paul A Gurbel, Udaya S Tantry, Robert F Storey   +2 more
exaly  

Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes

New England Journal of Medicine, 2007
Eugene Braunwald, Stefano De Servi, C Michael Gibson   +2 more
exaly  

Clopidogrel

Reactions Weekly, 2017
  +4 more sources

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials

Lancet, The, 2009
Michelle L O'donoghue, Eugene Braunwald, Elliott M Antman   +2 more
exaly  

Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis

Lancet, The, 2010
Marc S Sabatine
exaly  

Clopidogrel Resistance Is Associated With Increased Risk of Recurrent Atherothrombotic Events in Patients With Acute Myocardial Infarction

Circulation, 2004
Michael Shechter, Ilan Goldenberg, Naphtali Savion   +2 more
exaly  

Clopidogrel

Reactions Weekly, 2010
openaire   +2 more sources

Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data

Lancet, The, 2009
Rikke Sørensen, Charlotte Andersson, Lars Køber   +2 more
exaly